NEW YORK (Reuters Health) – A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), combination antithrombotic therapy with an anticoagulant and an antiplatelet increases the risk for clinically relevant bleeding with…
NEW YORK (Reuters Health) – Patients with an implantable converter-defibrillator (ICD) that uses fracture-prone Fidelis leads have similar survival rates as ICD patients with another type of lead,…
NEW YORK (Reuters Health) – Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – Ambulatory blood pressure monitoring (ABPM) is a better predictor of renal and cardiovascular events than office BP measurement in patients with chronic kidney…
NEW YORK (Reuters Health) – Patients with unprotected left main disease and right coronary artery chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) face an increased risk…
NEW YORK (Reuters Health) – An investigational drug AMR101 containing purified eicosapentaenoic acid and no docosahexaenoic acid reduces very high triglyceride levels by up to 45% compared to…
NEW YORK (Reuters Health) – Facilitated percutaneous coronary intervention (PCI), with prehospital fibrinolysis, is no better than primary PCI for patients who are very early in the course…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…